Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia

The BRAF-V600E mutation defines genetically hairy cell leukemia among B-cell leukemias and lymphomas. In solid tumors, BRAF-V600E is known to aberrantly activate the oncogenic MEK-ERK pathway, and targeted BRAF and/or MEK inhibitors have shown remarkable efficacy in clinical trials in melanoma patie...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tiacci, Enrico, Schiavoni, Gianluca, Martelli, Maria Paola, Boveri, Emanuela, Pacini, Roberta, Tabarrini, Alessia, Zibellini, Silvia, Santi, Alessia, Pettirossi, Valentina, Fortini, Elisabetta, Ascani, Stefano, Arcaini, Luca, Inghirami, Giorgio, Paulli, Marco, Falini, Brunangelo
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2013
Sujets:
Original Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659996/
https://ncbi.nlm.nih.gov/pubmed/23349307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.078071
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires